A Phase II, Open-label Pilot Study Evaluating the Safety and Activity of Nal-IRI in Combination With 5-FU and Oxaliplatin in Preoperative Treatment of Pancreatic Adenocarcinoma (NEO-Nal- IRI Study)
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Jul 2018
At a glance
- Drugs Irinotecan (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- Acronyms NEO-Nal- IRI Study
- 10 Jul 2018 Planned number of patients changed from 22 to 28.
- 29 May 2018 Planned initiation date changed from 1 Jun 2018 to 1 Aug 2018.
- 04 Apr 2018 New trial record